General Information of Drug (ID: DMBD9MQ)

Drug Name
DCB-AD1
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 2 [1]
Cross-matching ID
TTD ID
D09BCL

References

1 ClinicalTrials.gov (NCT00154635) Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease. U.S. National Institutes of Health.